摘要
目的评价红蓝光联合他扎罗汀治疗面部寻常型痤疮的临床效果和安全性。方法将入选的179例寻常型痤疮患者随机分为三组,对照1组(60例)予红蓝光治疗,对照2组(59例)予他扎罗汀治疗,治疗组(60例)予红蓝光联合他扎罗汀治疗,比较三组患者的临床疗效和不良反应。疗程均为8周。结果对照1组、对照2组、治疗组的有效率分别为71.67%,79.66%和95.00%。治疗组的有效率均高于其他两组,差异均有统计学意义(P均<0.01)。另外,三组患者的不良反应发生率差异无统计学意义(P>0.05)。结论红蓝光联合他扎罗汀治疗面部寻常型痤疮疗效好,不良反应轻。
Objective To observe the clinical effect of the combined therapy of red and blue light with 0. 1% tazarotene cream in the treatment of facial acne vulgaris. Methods A total of 179 cases were recruited for the study and randomly divided into three groups. Control group 1 treated with the red and blue light（60 cases）, control group 2 treated with the tazarotene（59 cases）, treating group treated with red and blue light combined with 0. 1% tazarotene cream（60 cases）. The effective rate and the adverse reaction rate were observed and recorded. All patients received 8 weeks of treatment. Results The effective rates were 71.67% in control group 1,79. 66% in control group 2,95. 00% in treating group. The therapeutic effect of treating group was significantly higher than two control groups （P 〈 0. 01 ）. The adverse reaction rate was no significant difference in them（P 〉 0. 05 ）. Conclusion Combined therapy of red and blue light with 0. 1% tazarotene cream in the treatment of facial ache vulgaris is effective and with few side reactions.
出处
《中国皮肤性病学杂志》
CAS
CSCD
北大核心
2015年第9期990-992,共3页
The Chinese Journal of Dermatovenereology
关键词
红蓝光
他扎罗汀
寻常型痤疮
临床观察
Red and blue light
Tazarotene
Acne vulgaris
Clinical observation
